A 34-year-old man presents via telehealth for a follow-up visit. Over the past four weeks, he has experienced persistent low mood, hypersomnia, extreme fatigue, and a loss of interest in his usual activities. Five years ago, he was hospitalized for an episode characterized by grandiosity, pressured speech, and a significantly decreased need for sleep. He has not taken any medications for the past six months. Which of the following are appropriate pharmacological treatments for this patient's current condition? (Select all that apply)
- QuetiapineAnswer
- LurasidoneAnswer
- CEscitalopram monotherapy
- DVenlafaxine monotherapy
- Olanzapine and fluoxetine combinationAnswer
Answer
The correct treatments are quetiapine, lurasidone, and the olanzapine and fluoxetine combination.
The patient's history of a manic episode requiring hospitalization confirms a diagnosis of bipolar I disorder. He is currently presenting with an acute bipolar depressive episode. The goal of treatment is to alleviate depressive symptoms without inducing a manic switch. Quetiapine, lurasidone, and the olanzapine-fluoxetine combination are all first-line, FDA-approved treatments for acute bipolar depression. They provide both mood-stabilizing and antidepressant effects.
Step-by-Step Solution
Key Concept
Acute depressive episodes in bipolar I disorder should be treated with specific second-generation antipsychotics (e.g., quetiapine, lurasidone) or combinations (e.g., olanzapine-fluoxetine) rather than antidepressant monotherapy, which carries a high risk of inducing mania.